Response to Harrell's commentary.
- Published in:
- Clinical Trials, 2024, v. 21, n. 4, p. 415, doi. 10.1177/17407745241251851
- By:
- Publication type:
- Article
Works matching IS 17407745 AND DT 2024 AND VI 21 AND IP 4
Results: 14
1
2
Commentary on van Lancker et al.
- Published in:
- Clinical Trials, 2024, v. 21, n. 4, p. 412, doi. 10.1177/17407745241251609
- By:
- Publication type:
- Article
3
Covariate adjustment in randomized controlled trials: General concepts and practical considerations.
- Published in:
- Clinical Trials, 2024, v. 21, n. 4, p. 399, doi. 10.1177/17407745241251568
- By:
- Publication type:
- Article
4
Evaluating treatment efficacy in hospitalized COVID-19 patients, with applications to Adaptive COVID-19 Treatment Trials.
- Published in:
- Clinical Trials, 2024, v. 21, n. 4, p. 500, doi. 10.1177/17407745241238443
- By:
- Publication type:
- Article
5
Rethinking the clinical research protocol: Lessons learned from the COVID-19 pandemic and recommendations for reducing noncompliance.
- Published in:
- Clinical Trials, 2024, v. 21, n. 4, p. 491, doi. 10.1177/17407745241232430
- By:
- Publication type:
- Article
6
A safety estimand for late phase clinical trials where the analysis period varies over the subjects.
- Published in:
- Clinical Trials, 2024, v. 21, n. 4, p. 483, doi. 10.1177/17407745241230933
- By:
- Publication type:
- Article
7
Assessing the current utilization status of wearable devices in clinical research.
- Published in:
- Clinical Trials, 2024, v. 21, n. 4, p. 470, doi. 10.1177/17407745241230287
- By:
- Publication type:
- Article
8
The use of linked administrative data in Australian randomised controlled trials: A scoping review.
- Published in:
- Clinical Trials, 2024, v. 21, n. 4, p. 516, doi. 10.1177/17407745231225618
- By:
- Publication type:
- Article
9
Research encouraging off-label use of quetiapine: A systematic meta-epidemiological analysis.
- Published in:
- Clinical Trials, 2024, v. 21, n. 4, p. 418, doi. 10.1177/17407745231225470
- By:
- Publication type:
- Article
10
Public involvement in Australian clinical trials: A systematic review.
- Published in:
- Clinical Trials, 2024, v. 21, n. 4, p. 507, doi. 10.1177/17407745231224533
- By:
- Publication type:
- Article
11
Assessing the impact of risk-based data monitoring on outcomes for a paediatric multicentre randomised controlled trial.
- Published in:
- Clinical Trials, 2024, v. 21, n. 4, p. 461, doi. 10.1177/17407745231222019
- By:
- Publication type:
- Article
12
Hierarchical Bayesian modeling of heterogeneous outcome variance in cluster randomized trials.
- Published in:
- Clinical Trials, 2024, v. 21, n. 4, p. 451, doi. 10.1177/17407745231222018
- By:
- Publication type:
- Article
13
A Bayesian adaptive design approach for stepped-wedge cluster randomized trials.
- Published in:
- Clinical Trials, 2024, v. 21, n. 4, p. 440, doi. 10.1177/17407745231221438
- By:
- Publication type:
- Article
14
The symbolic two-step method applied to cancer care delivery research: Safeguarding against designing an underpowered cluster randomized trial with a continuous outcome by accounting for the imprecision in the within- and between-center variation.
- Published in:
- Clinical Trials, 2024, v. 21, n. 4, p. 430, doi. 10.1177/17407745231219680
- By:
- Publication type:
- Article